Download
s12871-020-01217-1.pdf 846,67KB
WeightNameValue
1000 Titel
  • Prevention of postoperative bleeding after complex pediatric cardiac surgery by early administration of fibrinogen, prothrombin complex and platelets: a prospective observational study
1000 Autor/in
  1. Dennhardt, Nils |
  2. Sümpelmann, Robert |
  3. Horke, Alexander |
  4. Keil, Oliver |
  5. Nickel, Katja |
  6. Heiderich, Sebastian |
  7. Boethig, Dietmar |
  8. Beck, Christiane E. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-12-18
1000 Erschienen in
1000 Quellenangabe
  • 20(1):302
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12871-020-01217-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747387/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Postoperative bleeding is a major problem in children undergoing complex pediatric cardiac surgery. The primary aim of this prospective observational study was to evaluate the effect of an institutional approach consisting of early preventive fibrinogen, prothrombin complex and platelets administration on coagulation parameters and postoperative bleeding in children. The secondary aim was to study the rate of re-intervention and postoperative transfusion, the occurrence of thrombosis, length of mechanical ventilation, ICU stay and mortality.!##!Methods!#!In fifty children (age 0-6 years) with one or more predefined risk factors for bleeding after cardiopulmonary bypass (CPB), thrombelastography (TEG) and standard coagulation parameters were measured at baseline (T1), after CPB and reversal of heparin (T2), at sternal closure (T3) and after 12 h in the ICU (T4). Clinical bleeding was evaluated by the surgeon at T2 and T3 using a numeric rating scale (NRS, 0-10).!##!Results!#!After CPB and early administration of fibrinogen, prothrombin complex and platelets, the clinical bleeding evaluation score decreased from a mean value of 6.2 ± 1.9 (NRS) at T2 to a mean value of 2.1 ± 0.8 at T3 (NRS; P <  0.001). Reaction time (R), kinetic time (K), maximum amplitude (MA) and maximum amplitude of fibrinogen (MA-fib) improved significantly (P <  0.001 for all), and MA-fib correlated significantly with the clinical bleeding evaluation (r = 0.70, P <  0.001). The administered total amount of fibrinogen (mg kg!##!Conclusion!#!In this observational study of children with an increased risk of bleeding after CPB, an early preventive therapy with fibrinogen, prothrombin complex and platelets guided by clinical bleeding evaluation and TEG reduced bleeding and improved TEG and standard coagulation parameters significantly, with no occurrence of thrombosis or need for re-operation.!##!Trial registration!#!German Clinical Trials Register DRKS00018109 (retrospectively registered 27th August 2019).
1000 Sacherschließung
lokal Infant, Newborn [MeSH]
lokal Length of Stay/statistics
lokal Prothrombin Time [MeSH]
lokal Perioperative medicine and outcome
lokal Blood Coagulation Factors/drug effects [MeSH]
lokal Thrombelastography
lokal Thrombelastography [MeSH]
lokal Bleeding
lokal Cardiac Surgical Procedures/methods [MeSH]
lokal Infant [MeSH]
lokal Male [MeSH]
lokal Child [MeSH]
lokal Research Article
lokal Fibrinogen/therapeutic use [MeSH]
lokal Female [MeSH]
lokal Blood Platelets [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Treatment Outcome [MeSH]
lokal Fibrinogen
lokal Platelet Count [MeSH]
lokal Fibrinogen/administration
lokal Postoperative Hemorrhage/prevention
lokal Cardiopulmonary bypass
lokal Time [MeSH]
lokal Children
lokal Blood Coagulation Factors/therapeutic use [MeSH]
lokal Blood Coagulation/drug effects [MeSH]
lokal Child, Preschool [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-3831-1608|https://frl.publisso.de/adhoc/uri/U8O8bXBlbG1hbm4sIFJvYmVydA==|https://frl.publisso.de/adhoc/uri/SG9ya2UsIEFsZXhhbmRlcg==|https://frl.publisso.de/adhoc/uri/S2VpbCwgT2xpdmVy|https://frl.publisso.de/adhoc/uri/Tmlja2VsLCBLYXRqYQ==|https://frl.publisso.de/adhoc/uri/SGVpZGVyaWNoLCBTZWJhc3RpYW4=|https://frl.publisso.de/adhoc/uri/Qm9ldGhpZywgRGlldG1hcg==|https://frl.publisso.de/adhoc/uri/QmVjaywgQ2hyaXN0aWFuZSBFLg==
1000 Hinweis
  • DeepGreen-ID: 3ad0cfaa4eef48e497a8fd4548f18874 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466108.rdf
1000 Erstellt am 2023-11-16T18:41:15.813+0100
1000 Erstellt von 322
1000 beschreibt frl:6466108
1000 Zuletzt bearbeitet Fri Dec 01 03:40:46 CET 2023
1000 Objekt bearb. Fri Dec 01 03:40:46 CET 2023
1000 Vgl. frl:6466108
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466108 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source